Ezetimibe. The French authorities gradually confirm the lack of benefit.
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001384:Azetidines / Q000009:adverse effects / Q000627:therapeutic use*; D000069438:Ezetimibe; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*
D000924:Anticholesteremic Agents; D001384:Azetidines; D000069438:Ezetimibe